Impact of WHO guidelines on trends in HIV testing and ART initiation among children living with HIV in Zambia.
Anti-Retroviral Agents
/ therapeutic use
Child, Preschool
Drug Administration Schedule
Female
HIV Infections
/ diagnosis
HIV Testing
/ trends
Humans
Infant
Male
Mass Screening
Practice Guidelines as Topic
Retrospective Studies
Rural Population
Survival Analysis
World Health Organization
Zambia
/ epidemiology
ART initiation
Childhood HIV
HIV testing
HIV treatment
HIV trends in Zambia
Journal
AIDS research and therapy
ISSN: 1742-6405
Titre abrégé: AIDS Res Ther
Pays: England
ID NLM: 101237921
Informations de publication
Date de publication:
14 05 2020
14 05 2020
Historique:
received:
04
02
2020
accepted:
05
05
2020
entrez:
16
5
2020
pubmed:
16
5
2020
medline:
2
7
2021
Statut:
epublish
Résumé
About 13 years since the introduction of antiretroviral therapy (ART) for children living with HIV (CLHIV) in Zambia, HIV/AIDS testing and treatment guidelines for children have evolved over the years with limited documentation of long-term trends in the numbers testing HIV positive and initiating ART. We examined trends in HIV testing and ART initiation in Zambia. We conducted a retrospective cohort study using routinely collected patient level data from 496 health facilities across Zambia. We used Poisson regression to derive incident rate ratios and 95% confidence intervals (95% CI) for background characteristics and used a Cuzick non-parametric test for trends to test the 13-year trends. Median time from testing to ART initiation in days and incidence rates were derived using life tables in survival analysis. We used multi-level random effects Poisson regression model to determine variations in time from HIV testing to ART initiation by facility. Overall, the cumulative proportion of the children who tested positive and initiated antiretroviral therapy (ART for HIV) from 2004 to 2017 was 69% (n = 99 592). During the period under review proportions of ART initiation increased from 52% in 2004-2006 to 97% in 2016-2017 (P < 0.001) and time from testing to ART initiation reduced from a median of 17 days IQR (1-161) in 2004 to one day IQR (1-14), P < 0.001 in 2016-2017. CLHIV were 15 times more likely to be initiated on ART in 2016-17 compared to period 2004-6 (IRR = 15.2, 95% CI 14.7-15.7). Time to ART initiation increased with age and was higher in rural health facilities compared to urban facilities. About 11% of the variability in time to ART initiation in children could be attributed to differences between facilities. The substantial increase in ART initiation and reduction in time to ART initiation among CLHIV identified in this study, reflects improvements in the paediatric HIV programme in Zambia in relation to health care delivery and adherence to national testing and treatment guidelines that were adapted from WHO guidelines. However, age-related differentials in rates of ART initiation suggests that urgent interventions are needed to sustain and further improve programme performance.
Sections du résumé
BACKGROUND
About 13 years since the introduction of antiretroviral therapy (ART) for children living with HIV (CLHIV) in Zambia, HIV/AIDS testing and treatment guidelines for children have evolved over the years with limited documentation of long-term trends in the numbers testing HIV positive and initiating ART. We examined trends in HIV testing and ART initiation in Zambia.
METHODS
We conducted a retrospective cohort study using routinely collected patient level data from 496 health facilities across Zambia. We used Poisson regression to derive incident rate ratios and 95% confidence intervals (95% CI) for background characteristics and used a Cuzick non-parametric test for trends to test the 13-year trends. Median time from testing to ART initiation in days and incidence rates were derived using life tables in survival analysis. We used multi-level random effects Poisson regression model to determine variations in time from HIV testing to ART initiation by facility.
RESULTS
Overall, the cumulative proportion of the children who tested positive and initiated antiretroviral therapy (ART for HIV) from 2004 to 2017 was 69% (n = 99 592). During the period under review proportions of ART initiation increased from 52% in 2004-2006 to 97% in 2016-2017 (P < 0.001) and time from testing to ART initiation reduced from a median of 17 days IQR (1-161) in 2004 to one day IQR (1-14), P < 0.001 in 2016-2017. CLHIV were 15 times more likely to be initiated on ART in 2016-17 compared to period 2004-6 (IRR = 15.2, 95% CI 14.7-15.7). Time to ART initiation increased with age and was higher in rural health facilities compared to urban facilities. About 11% of the variability in time to ART initiation in children could be attributed to differences between facilities.
CONCLUSIONS
The substantial increase in ART initiation and reduction in time to ART initiation among CLHIV identified in this study, reflects improvements in the paediatric HIV programme in Zambia in relation to health care delivery and adherence to national testing and treatment guidelines that were adapted from WHO guidelines. However, age-related differentials in rates of ART initiation suggests that urgent interventions are needed to sustain and further improve programme performance.
Identifiants
pubmed: 32408890
doi: 10.1186/s12981-020-00277-0
pii: 10.1186/s12981-020-00277-0
pmc: PMC7226945
doi:
Substances chimiques
Anti-Retroviral Agents
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18Références
Infect Dis Poverty. 2015 May 04;4:18
pubmed: 25954505
BMC Infect Dis. 2015 Mar 26;15:157
pubmed: 25881135
AIDS Care. 2013;25(12):1520-6
pubmed: 23528004
PLoS Med. 2010 Feb 02;7(2):e1000178
pubmed: 20126383
PLoS One. 2013 Dec 09;8(12):e81037
pubmed: 24363808
JAMA. 2006 Aug 16;296(7):782-93
pubmed: 16905784
JAMA. 2007 Oct 24;298(16):1888-99
pubmed: 17954540
PLoS One. 2017 Jan 12;12(1):e0169871
pubmed: 28081230
BMC Pediatr. 2010 Jul 30;10:54
pubmed: 20673355
J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):202-8
pubmed: 19504732
AIDS. 2009 Sep 24;23(15):2039-46
pubmed: 19684508